Adverse drug reactions and the skin:
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Buch |
| Sprache: | English |
| Veröffentlicht: |
Oxford u.a.
Blackwell Scientific Publ.
1992
|
| Ausgabe: | 1. publ. |
| Schlagworte: | |
| Online-Zugang: | Inhaltsverzeichnis |
| Beschreibung: | Literaturangaben |
| Beschreibung: | XII, 394 S. zahlr. Ill. |
| ISBN: | 0632033495 |
Internformat
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV005908262 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | t | ||
| 008 | 921228s1992 a||| |||| 00||| eng d | ||
| 020 | |a 0632033495 |9 0-632-03349-5 | ||
| 035 | |a (OCoLC)27852683 | ||
| 035 | |a (DE-599)BVBBV005908262 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-19 |a DE-355 |a DE-578 | ||
| 050 | 0 | |a RM305 | |
| 082 | 0 | |a 616.5061 |2 20 | |
| 084 | |a XI 2078 |0 (DE-625)152980:12985 |2 rvk | ||
| 084 | |a WR 165 |2 nlm | ||
| 100 | 1 | |a Breathnach, Stephen M. |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Adverse drug reactions and the skin |c Stephen M. Breathnach and Helmut Hintner |
| 250 | |a 1. publ. | ||
| 264 | 1 | |a Oxford u.a. |b Blackwell Scientific Publ. |c 1992 | |
| 300 | |a XII, 394 S. |b zahlr. Ill. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 500 | |a Literaturangaben | ||
| 650 | 7 | |a Bijwerkingen |2 gtt | |
| 650 | 7 | |a Geneesmiddelen |2 gtt | |
| 650 | 7 | |a Huidziekten |2 gtt | |
| 650 | 4 | |a Médicaments - Effets secondaires | |
| 650 | 4 | |a Peau - Maladies - Chimiothérapie | |
| 650 | 4 | |a Pharmacologie dermatologique | |
| 650 | 4 | |a Dermatopharmacology | |
| 650 | 4 | |a Drug Eruptions |x epidemiology | |
| 650 | 4 | |a Drug Eruptions |x etiology | |
| 650 | 4 | |a Drug Eruptions |x therapy | |
| 650 | 4 | |a Drug-exanthems | |
| 650 | 4 | |a Drugs |x Side effects | |
| 650 | 4 | |a Pharmaceutical Preparations |x adverse effects | |
| 650 | 4 | |a Skin |x Diseases | |
| 650 | 0 | 7 | |a Hautkrankheit |0 (DE-588)4023852-0 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Haut |0 (DE-588)4023838-6 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Arzneimittelnebenwirkung |0 (DE-588)4003134-2 |2 gnd |9 rswk-swf |
| 689 | 0 | 0 | |a Arzneimittelnebenwirkung |0 (DE-588)4003134-2 |D s |
| 689 | 0 | 1 | |a Haut |0 (DE-588)4023838-6 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Hautkrankheit |0 (DE-588)4023852-0 |D s |
| 689 | 1 | 1 | |a Arzneimittelnebenwirkung |0 (DE-588)4003134-2 |D s |
| 689 | 1 | |8 1\p |5 DE-604 | |
| 700 | 1 | |a Hintner, Helmut |e Verfasser |4 aut | |
| 856 | 4 | 2 | |m GBV Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=003698279&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-003698279 | ||
| 883 | 1 | |8 1\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
Datensatz im Suchindex
| _version_ | 1804120097033289728 |
|---|---|
| adam_text | ADVERSE DRUG REACTIONS AND THE SKIN STEPHEN M. BREATHNACH MA MD PHD FRCP
CONSULTANT DERMATOLOGIST, ST JOHN S DERMATOLOGY CENTRE; SENIOR LECTURER,
ST JOHN S INSTITUTE OF DERMATOLOGY, ST THOMAS S HOSPITAL LONDON, UK AND
HELMUT HINTNER MD PROFESSOR OF DERMATOLOGY, DEPARTMENT OF DERMATOLOGY,
GENERAL HOSPITAL, SALZBURG, AUSTRIA OXFORD BLACKWELL SCIENTIFIC
PUBLICATIONS LONDON EDINBURGH BOSTON MELBOURNE PARIS BERLIN VIENNA
CONTENTS PREFACE, XI PART 1: EPIDEMIOLOGY AND PATHOMECHANISMS
INTRODUCTION AND INCIDENCE OF DRUG REACTIONS, 3 1.1 INTRODUCTION 1.2 THE
INCIDENCE OF DRUG REACTIONS COLLECTION OF DATA GENERAL INCIDENCE OF
ADVERSE DRUG REACTIONS DIFFERENTIAL RISK OF ADVERSE DRUG REACTIONS
AMONGST PATIENT GROUPS FREQUENCY OF ALL DRUG REACTIONS IN RELATION TO
TYPES OF MEDICATION INCIDENCE OF DRUG ERUPTIONS CLASSIFICATION AND
MECHANISMS OF DRUG REACTIONS, 14 2.1 NON-IMMUNOLOGICAL DRUG REACTIONS
OVERDOSAGE SIDE-EFFECTS CUMULATIVE TOXIDTY DELAYED TOXICITY FACULTATIVE
EFFECTS DRUG INTERACTIONS METABOLIC CHANGES TERATOGENICITY AND OTHER
EFFECTS ON THE FETUS ANAPHYLACTOID REACTIONS EXACERBATION OF DISEASE
INTOLERANCE IDIOSYNCRASY PHARMACOGENETIC MECHANISMS DRUG-INDUCED
CHROMOSOMAL DAMAGE 2.2 MISCELLANEOUS REACTIONS JARISCH*HERXHEIMER
REACTION INFECTIOUS MONONUDEOSIS*AMPICILLIN REACTION 2.3 IMMUNOLOGICAL
DRUG REACTIONS CLINICAL FEATURES DISTINGUISHING ALLERGIC FROM
NON-ALLERGIC DRUG REACTIONS FACTORS CONCERNED IN THE DEVELOPMENT OF
HYPERSENSITIVITY THE DURATION OF HYPERSENSITIVITY 2.4 TYPES OF
IMMUNOLOGICAL REACTION IGE-DEPENDENT (TYPE I) DRUG REACTIONS: URTICARIA
AND ANAPHYLAXIS ANTIBODY-MEDIATED (TYPE II) DRUG REACTIONS IMMUNE
COMPLEX-DEPENDENT (TYPE III) DRUG REACTIONS [V] CELL-MEDIATED REACTIONS
(TYPE IV REACTIONS) THE SKIN IMMUNE SYSTEM AND CUTANEOUS INFLAMMATION
GRAFT-VERSUS-HOST DISEASE AS A MODEL FOR DRUG ERUPTIONS JONES-MOTE
(CUTANEOUS BASOPHIL) HYPERSENSITIVITY PART 2: PATTERNS OF CLINICAL
DISEASE 3 TYPES OF CLINICAL REACTION, 41 3.1 EXANTHEMATIC
(MACULOPAPULAR) REACTIONS 3.2 PURPURA 3.3 ANNULAR ERYTHEMA 3.4
PITYRIASIS ROSEA-LIKE ERUPTIONS 3.5 PSORIASIFORM ERUPTIONS 3.6
ERYTHRODERMA AND EXFOLIATIVE DERMATITIS 3.7 ANAPHYLAXIS AND
ANAPHYLACTOID REACTIONS 3.8 URTICARIA 3.9 SERUM SICKNESS 3.10 ERYTHEMA
MULTIFORME AND THE STEVENS-JOHNSON SYNDROME 3.11 TOXIC EPIDERMAL
NECROLYSIS 3.12 FIXED DRUG ERUPTIONS 3.13 LICHENOID ERUPTIONS 3.14
PHOTOSENSITIVITY 3.15 PIGMENTARY ABNORMALITIES 3.16 ACNEIFORM AND
PUSTULAR ERUPTIONS 3.17 ECZEMATOUS ERUPTIONS 3.18 BULLOUS ERUPTIONS 3.19
PORPHYRIA AND PSEUDOPORPHYRIA 3.20 DRUG-INDUCED BULLOUS PEMPHIGOID 3.21
DRUG-INDUCED PEMPHIGUS 3.22 VASCULITIS 3.23 LUPUS ERYTHEMATOSUS
(LE)-LIKE SYNDROME 3.24 DRUG-INDUCED DERMATOMYOSITIS 3.25
SCLERODERMA-LIKE REACTIONS 3.26 EOSINOPHILIA-MYALGIA SYNDROME 3.27
ERYTHEMA NODOSUM 3.28 PSEUDOLYMPHOMATOUS ERUPTIONS 3.29 ERYTHROMELALGIA
3.30 DRUG-INDUCED ALOPECIA 3.31 DRUG-INDUCED HYPERTRICHOSIS 3.32
DRUG-INDUCED NAIL ABNORMALITIES 3.33 DRUG-INDUCED ORAL CONDITIONS 3.34
OLIGOSPERMIA PART 3: IMPORTANT OR WIDELY PRESCRIBED DRUGS 4
ANTIBACTERIAL DRUGS, 137 4.1 (3-LACTAM ANTIBIOTICS 4.2 TETRACYCLINES 4.3
SULPHONAMIDES 4.4 AMINOGLYCOSIDES 4.5 MISCELLANEOUS ANTIBIOTICS 4.6
ANTITUBERCULOUS DRUGS 4.7 ANTILEPROSY DRUGS 4.8 METRONIDAZOLE AND
TINIDAZOLE 4.9 QUINOLONES 4.10 URINARY TRACT ANTIBIOTICS 4.11 TOPICAL
ANTIBIOTICS [VI] 5 ANTIFUNGAL AND ANTIVIRAL DRUGS, 168 5.1 ANTIFUNGAL
DRUGS 5.2 ANTIVIRAL DRUGS 6 ANTIMALARIAL AND ANTIHELMINTHIC DRUGS, 174
6.1 ANTIMALARIALS 6.2 ANTIHELMINTHICS 6.3 DRUGS FOR PNEUMOCYSTIS 7
NON-STEROIDAL ANTI-INFLAMMATORY AGENTS, 180 7.1 ACETYLSALICYLIC ADD AND
RELATED COMPOUNDS 7.2 OTHER NON-STEROIDAL ANTI-INFLAMMATORY AGENTS 7.3
MISCELLANEOUS ANTI-INFLAMMATORY AGENTS 8 DRUGS ACTING ON THE CENTRAL
NERVOUS SYSTEM, 196 8.1 ANTIDEPRESSANTS TRICYCLICS AND RELATED COMPOUNDS
MONOAMINE-OXIDASE INHIBITORS LITHIUM 8.2 HYPNOTICS, SEDATIVES AND
ANXIOLYTICS BARBITURATES BENZODIAZEPINES MISCELLANEOUS DRUGS 8.3
ANTIPSYCHOTICS PHENOTHIAZINES 8.4 DRUGS FOR ALCOHOLISM 8.5
ANTICONVULSANTS 8.6 OPIOID ANALGESICS AND AMPHETAMINE 8.7
ANTI-PARKINSONIAN DRUGS 8.8 ANTIVERTIGO DRUGS AND CEREBROVASCULAR
DILATORS 9 DRUGS ACTING ON THE CARDIOVASCULAR AND RESPIRATORY SYSTEMS,
215 9.1 CARDIAC ANTIARRHYTHMIC DRUGS 9.2 (3-ADRENOCEPTOR BLOCKING AGENTS
9.3 ANTIHYPERTENSIVE DRUGS AND VASODILATORS ANGIOTENSIN-CONVERTING
ENZYME (ACE) INHIBITORS CALDUM CHANNEL BLOCKERS CENTRALLY ACTING
ANTIHYPERTENSIVE DRUGS ADRENERGIC NEURONE BLOCKING AGENTS VASODILATOR
ANTIHYPERTENSIVE DRUGS NITRATE VASODILATORS 9.4 DIURETICS 9.5
MISCELLANEOUS CARDIOVASCULAR DRUGS 9.6 P-AGONIST DRUGS 9.7
ANTIMUSCARINIC BRONCHODILATORS 9.8 MISCELLANEOUS RESPIRATORY SYSTEM
DRUGS 10 METALS AND METAL ANTAGONISTS, 236 10.1 METALS 10.2 METAL
ANTAGONISTS 11 ANTICOAGULANTS, FIBRINOLYTIC AGENTS, AND ANTIPLATELET
DRUGS, 247 IN ORAL ANTICOAGULANTS 11.2 HEPARIN: PARENTERAL ANTICOAGULANT
[VII] 11.3 PROTAMINE: HEPARIN ANTAGONIST 11.4 FIBRINOLYTIC DRUGS 11.5
ANTIPLATELET DRUGS 12 VITAMINS, 254 12.1 VITAMIN A 12.2 RETINOIDS 12.3
VITAMIN B 12.4 VITAMIN C (ASCORBIC ADD) 12.5 VITAMIN E (A-TOCOPHEROL)
12.6 VITAMIN K 13 HORMONES AND RELATED COMPOUNDS, 267 13.1
ADRENOCORTICOTROPHIC HORMONE (ACTH) AND CORTICOSTEROIDS 13.2 OESTROGENS
AND RELATED COMPOUNDS 13.3 ANDROGENS 13.4 INSULIN 13.5 THYROXINE 13.6
ANTITHYROID DRUGS 14 CHEMOTHERAPEUTIC AGENTS, 281 14.1 GENERAL
SIDE-EFFECTS 14.2 ALKYLATING AGENTS 14.3 CYTOTOXIC ANTIBIOTICS 14.4
ANTIMETABOLITES 14.5 VINCA ALKALOIDS AND ETOPOSIDE 14.6 ENZYMES 14.7
MISCELLANEOUS CHEMOTHERAPEUTIC AGENTS 15 DRUGS AFFECTING THE IMMUNE
RESPONSE, 305 15.1 CYCLOSPORIN A AND FK506 15.2 PUVA THERAPY 15.3
IMMUNOTHERAPY SERA VACDNES HYPOSENSITIZATION IMMUNOTHERAPY BACILLE
CALMETTE*GU^RIN (BCG) VACCINATION CYTOKINES 15.4 MISCELLANEOUS 15.5
ANTIHISTAMINES 16 INJECTIONS, INFUSIONS AND PROCEDURES, 328 16.1
RADIOGRAPHIC CONTRAST MEDIA AND RADIOPHARMACEUTICALS 16.2 HALIDES 16.3
AGENTS USED IN GENERAL ANAESTHESIA 16.4 LOCAL ANAESTHETIC AGENTS 16.5
INFUSIONS AND INJECTIONS INTRAVENOUS INFUSION BLOOD TRANSFUSION AND
LEUCOPHERESIS 16.6 RENAL DIALYSIS 16.7 NECROSIS FROM INTRAMUSCULAR
INJECTIONS 16.8 POLYVINYLPYRROLIDONE 16.9 CHYMOPAPAIN INJECTION OF
INTERVERTEBRAL DISCS 16.10 DERMAL IMPLANTS 16.11 SILICONE 16.12
DIAGNOSTIC TESTS FOR TUBERCULOSIS [VIII] 17 DRUGS AFFECTING METABOLISM
OR GASTROINTESTINAL FUNCTION, 342 17.1 HYPOGLYCAEMIC DRUGS 17.2 LIPID
LOWERING DRUGS 17.3 DRUGS FOR GASTROINTESTINAL ULCERATION 17.4 LAXATIVES
18 ADDITIVES, HERBS, HOMOEOPATHY AND NATUROPATHY, AND ENVIRONMENTAL
CHEMICALS, 345 18.1 FOOD AND DRUG ADDITIVES 18.2 HERBAL REMEDIES,
HOMOEOPATHY AND NATUROPATHY 18.3 INDUSTRIAL AND OTHER EXPOSURE TO
CHEMICALS 19 LOCAL AND SYSTEMIC EFFECTS OF TOPICAL APPLICATIONS, 351
PART 4: THE MANAGEMENT OF DRUG REACTIONS 20 DIAGNOSIS, 363 20.1 GENERAL
PRINCIPLES 20.2 DRUG HISTORY 20.3 DRUG ELIMINATION 20.4 SKIN TESTING
PATCH TESTING 20.5 IN VITRO TESTS 20.6 CHALLENGE TESTS 21 TREATMENT OF
DRUG ERUPTIONS, 376 21.1 GENERAL CONSIDERATIONS 21.2 ANAPHYLAXIS 21.3
EXFOLIATIVE DERMATITIS/ERYTHRODERMA 21.4 TOXIC EPIDERMAL NECROLYSIS 21.5
DESENSITIZATION INDEX, 385 [IX]
|
| any_adam_object | 1 |
| author | Breathnach, Stephen M. Hintner, Helmut |
| author_facet | Breathnach, Stephen M. Hintner, Helmut |
| author_role | aut aut |
| author_sort | Breathnach, Stephen M. |
| author_variant | s m b sm smb h h hh |
| building | Verbundindex |
| bvnumber | BV005908262 |
| callnumber-first | R - Medicine |
| callnumber-label | RM305 |
| callnumber-raw | RM305 |
| callnumber-search | RM305 |
| callnumber-sort | RM 3305 |
| callnumber-subject | RM - Therapeutics and Pharmacology |
| classification_rvk | XI 2078 |
| ctrlnum | (OCoLC)27852683 (DE-599)BVBBV005908262 |
| dewey-full | 616.5061 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.5061 |
| dewey-search | 616.5061 |
| dewey-sort | 3616.5061 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| edition | 1. publ. |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02370nam a2200637 c 4500</leader><controlfield tag="001">BV005908262</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">921228s1992 a||| |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0632033495</subfield><subfield code="9">0-632-03349-5</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)27852683</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV005908262</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-19</subfield><subfield code="a">DE-355</subfield><subfield code="a">DE-578</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RM305</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.5061</subfield><subfield code="2">20</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XI 2078</subfield><subfield code="0">(DE-625)152980:12985</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">WR 165</subfield><subfield code="2">nlm</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Breathnach, Stephen M.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Adverse drug reactions and the skin</subfield><subfield code="c">Stephen M. Breathnach and Helmut Hintner</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">1. publ.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Oxford u.a.</subfield><subfield code="b">Blackwell Scientific Publ.</subfield><subfield code="c">1992</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XII, 394 S.</subfield><subfield code="b">zahlr. Ill.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Literaturangaben</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Bijwerkingen</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Geneesmiddelen</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Huidziekten</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Médicaments - Effets secondaires</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Peau - Maladies - Chimiothérapie</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmacologie dermatologique</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Dermatopharmacology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Eruptions</subfield><subfield code="x">epidemiology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Eruptions</subfield><subfield code="x">etiology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Eruptions</subfield><subfield code="x">therapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug-exanthems</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs</subfield><subfield code="x">Side effects</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical Preparations</subfield><subfield code="x">adverse effects</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Skin</subfield><subfield code="x">Diseases</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Hautkrankheit</subfield><subfield code="0">(DE-588)4023852-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Haut</subfield><subfield code="0">(DE-588)4023838-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelnebenwirkung</subfield><subfield code="0">(DE-588)4003134-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Arzneimittelnebenwirkung</subfield><subfield code="0">(DE-588)4003134-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Haut</subfield><subfield code="0">(DE-588)4023838-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Hautkrankheit</subfield><subfield code="0">(DE-588)4023852-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Arzneimittelnebenwirkung</subfield><subfield code="0">(DE-588)4003134-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hintner, Helmut</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">GBV Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=003698279&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-003698279</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield></record></collection> |
| id | DE-604.BV005908262 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T16:36:40Z |
| institution | BVB |
| isbn | 0632033495 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-003698279 |
| oclc_num | 27852683 |
| open_access_boolean | |
| owner | DE-19 DE-BY-UBM DE-355 DE-BY-UBR DE-578 |
| owner_facet | DE-19 DE-BY-UBM DE-355 DE-BY-UBR DE-578 |
| physical | XII, 394 S. zahlr. Ill. |
| publishDate | 1992 |
| publishDateSearch | 1992 |
| publishDateSort | 1992 |
| publisher | Blackwell Scientific Publ. |
| record_format | marc |
| spelling | Breathnach, Stephen M. Verfasser aut Adverse drug reactions and the skin Stephen M. Breathnach and Helmut Hintner 1. publ. Oxford u.a. Blackwell Scientific Publ. 1992 XII, 394 S. zahlr. Ill. txt rdacontent n rdamedia nc rdacarrier Literaturangaben Bijwerkingen gtt Geneesmiddelen gtt Huidziekten gtt Médicaments - Effets secondaires Peau - Maladies - Chimiothérapie Pharmacologie dermatologique Dermatopharmacology Drug Eruptions epidemiology Drug Eruptions etiology Drug Eruptions therapy Drug-exanthems Drugs Side effects Pharmaceutical Preparations adverse effects Skin Diseases Hautkrankheit (DE-588)4023852-0 gnd rswk-swf Haut (DE-588)4023838-6 gnd rswk-swf Arzneimittelnebenwirkung (DE-588)4003134-2 gnd rswk-swf Arzneimittelnebenwirkung (DE-588)4003134-2 s Haut (DE-588)4023838-6 s DE-604 Hautkrankheit (DE-588)4023852-0 s 1\p DE-604 Hintner, Helmut Verfasser aut GBV Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=003698279&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis 1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk |
| spellingShingle | Breathnach, Stephen M. Hintner, Helmut Adverse drug reactions and the skin Bijwerkingen gtt Geneesmiddelen gtt Huidziekten gtt Médicaments - Effets secondaires Peau - Maladies - Chimiothérapie Pharmacologie dermatologique Dermatopharmacology Drug Eruptions epidemiology Drug Eruptions etiology Drug Eruptions therapy Drug-exanthems Drugs Side effects Pharmaceutical Preparations adverse effects Skin Diseases Hautkrankheit (DE-588)4023852-0 gnd Haut (DE-588)4023838-6 gnd Arzneimittelnebenwirkung (DE-588)4003134-2 gnd |
| subject_GND | (DE-588)4023852-0 (DE-588)4023838-6 (DE-588)4003134-2 |
| title | Adverse drug reactions and the skin |
| title_auth | Adverse drug reactions and the skin |
| title_exact_search | Adverse drug reactions and the skin |
| title_full | Adverse drug reactions and the skin Stephen M. Breathnach and Helmut Hintner |
| title_fullStr | Adverse drug reactions and the skin Stephen M. Breathnach and Helmut Hintner |
| title_full_unstemmed | Adverse drug reactions and the skin Stephen M. Breathnach and Helmut Hintner |
| title_short | Adverse drug reactions and the skin |
| title_sort | adverse drug reactions and the skin |
| topic | Bijwerkingen gtt Geneesmiddelen gtt Huidziekten gtt Médicaments - Effets secondaires Peau - Maladies - Chimiothérapie Pharmacologie dermatologique Dermatopharmacology Drug Eruptions epidemiology Drug Eruptions etiology Drug Eruptions therapy Drug-exanthems Drugs Side effects Pharmaceutical Preparations adverse effects Skin Diseases Hautkrankheit (DE-588)4023852-0 gnd Haut (DE-588)4023838-6 gnd Arzneimittelnebenwirkung (DE-588)4003134-2 gnd |
| topic_facet | Bijwerkingen Geneesmiddelen Huidziekten Médicaments - Effets secondaires Peau - Maladies - Chimiothérapie Pharmacologie dermatologique Dermatopharmacology Drug Eruptions epidemiology Drug Eruptions etiology Drug Eruptions therapy Drug-exanthems Drugs Side effects Pharmaceutical Preparations adverse effects Skin Diseases Hautkrankheit Haut Arzneimittelnebenwirkung |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=003698279&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| work_keys_str_mv | AT breathnachstephenm adversedrugreactionsandtheskin AT hintnerhelmut adversedrugreactionsandtheskin |